Stonepine Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001440771

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q2 2026 · 83 positions · Total reported value $151.28M · Top-10 concentration 44.6% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 72.7% · 16 new · 27 cut · 29 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.9% · vs SPY -5.0% · Prev Value $151.28M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.9% · vs SPY -7.1% · Latest Value $130.24M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2026 13F filing, Stonepine Capital Management, LLC disclosed 83 equity positions with a combined reported value of $151.28M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 44.6% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were VSTM ($12.80M), TENX ($9.60M), NKTR ($8.42M). By sector, the heaviest allocations are Health Care 99.8%, Industrials 0.2%. Versus the prior quarter, allocation shifted toward Health Care (+36.5pp) and away from Real Estate (-1.4pp), Other (-34.9pp).

Versus the prior quarter, Stonepine Capital Management, LLC opened 16 new positions, trimmed 27 and fully exited 29, a turnover rate of 72.7% of positions. The portfolio's overlap with the prior quarter was 63% of names.

The largest new positions opened in Q2 2026 were INSM ($5.60M), ELOX ($5.51M), MDT ($4.38M).

Of the 29 positions fully exited versus the prior quarter, the largest were XBI ($51.09M), TERN ($5.27M), ARE ($2.32M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • INSM INSMED INC · $5.60M
  • ELOX ELOXX PHARMACEUTICALS INC · $5.51M
  • MDT MEDTRONIC PLC · $4.38M
  • INDV INDIVIOR PHARMACEUTICALS INC · $4.10M
  • ABT ABBOTT LABORATORIES · $3.80M
  • BSX BOSTON SCIENTIFIC CORP · $3.25M
  • BMRN BIOMARIN PHARMACEUTICAL INC · $3.12M
  • SPRB SPRUCE BIOSCIENCES INC · $1.55M

Fully Exited (vs previous quarter)

  • XBI SPDR SERIES TRUST · prev qtr: $51.09M
  • TERN TERNS PHARMACEUTICALS INC · prev qtr: $5.27M
  • ARE ALEXANDRIA REAL ESTATE EQ IN · prev qtr: $2.32M
  • ACAD ACADIA PHARMACEUTICALS INC · prev qtr: $2.23M
  • XOMA XOMA ROYALTY CORPORATION · prev qtr: $2.18M
  • SRZN SURROZEN INC · prev qtr: $961.44K · history
  • VRCA VERRICA PHARMACEUTICALS INC · prev qtr: $527.60K
  • CADL CANDEL THERAPEUTICS INC · prev qtr: $502.25K

Insider Transactions (Form 4)

Latest Stonepine Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Stonepine Capital Management, LLC is an SEC-registered 13F filer based in Bend, OR, United States. As of Q2 2026 it reported 83 US equity positions with a combined value of $151.28M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BEND, OR, United States
  • SEC registration: 801-136874 (status: Approved), registered 2026-07-22
  • Regulatory AUM (Form ADV): $181.00M as of 2026-06-26
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: stonepinecap.com

Portfolio Structure

  • 83 positions · $151.28M reported value (Q2 2026)
  • Top 10 holdings = 44.6% of reported value
  • Largest position: VSTM (VERASTEM INC) at 8.5%
  • Average position size: $1.82M

Sector Tilt

  • Health Care 99.8%
  • Industrials 0.2%
  • Materials 0.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 23 new, 28 added, 24 reduced, 12 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 99.8%
Materials 0.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 3.35M $12.80M 8.46%
8.46%
Add
2 660.00K $9.60M 6.35%
6.35%
Reduce
3 120.65K $8.42M 5.57%
5.57%
Add
4 740.00K $6.19M 4.09%
4.09%
Hold
5 1.39M $6.07M 4.01%
4.01%
Hold
6 40.00K $5.60M 3.70%
3.70%
New
7 397.16K $5.51M 3.64%
3.64%
New
8 345.18K $4.86M 3.21%
3.21%
Hold
9 50.00K $4.38M 2.89%
2.89%
New
10 100.00K $4.10M 2.71%
2.71%
New
11 425.00K $3.99M 2.63%
2.63%
Add
12 40.00K $3.80M 2.51%
2.51%
New
13 491.62K $3.72M 2.46%
2.46%
Add
14 258.70K $3.71M 2.45%
2.45%
Reduce
15 557.28K $3.44M 2.28%
2.28%
Add
16 50.00K $3.25M 2.15%
2.15%
New
17 456.44K $3.19M 2.11%
2.11%
Add
18 420.00K $3.15M 2.08%
2.08%
Hold
19 50.00K $3.12M 2.07%
2.07%
New
20 917.10K $2.85M 1.89%
1.89%
Add
21 551.69K $2.67M 1.76%
1.76%
Reduce
22 225.99K $2.17M 1.43%
1.43%
Add
23 245.52K $2.12M 1.40%
1.40%
Add
24 280.00K $2.10M 1.39%
1.39%
Add
25 2.66M $2.00M 1.32%
1.32%
Add
26 912.92K $1.96M 1.30%
1.30%
Add
27 3.31M $1.73M 1.14%
1.14%
Reduce
28 28.80K $1.55M 1.03%
1.03%
New
29 100.00K $1.50M 0.99%
0.99%
Add
30 863.00K $1.29M 0.86%
0.86%
Add
31 500.00K $1.25M 0.83%
0.83%
Add
32 2.20M $1.13M 0.75%
0.75%
Add
33 14.47K $1.07M 0.71%
0.71%
Reduce
34 815.44K $1.06M 0.70%
0.70%
Add
35 224.99K $1.05M 0.69%
0.69%
Reduce
36 150.00K $1.05M 0.69%
0.69%
Hold
37 100.00K $1.00M 0.66%
0.66%
Hold
38 695.29K $980.36K 0.65%
0.65%
Add
39 50.00K $973.50K 0.64%
0.64%
New
40 199.49K $965.51K 0.64%
0.64%
Add
41 751.61K $924.48K 0.61%
0.61%
Reduce
42 85.01K $922.36K 0.61%
0.61%
Add
43 5.29M $886.90K 0.59%
0.59%
New
44 364.25K $866.92K 0.57%
0.57%
Add
45 129.28K $854.54K 0.56%
0.56%
Reduce
46 25.00K $834.75K 0.55%
0.55%
New
47 396.18K $804.24K 0.53%
0.53%
Reduce
48 161.58K $783.68K 0.52%
0.52%
Reduce
49 205.00K $768.75K 0.51%
0.51%
Add
50 250.00K $750.00K 0.50%
0.50%
Add

FAQ

What did Stonepine Capital Management, LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, Stonepine Capital Management, LLC reported 83 equity positions worth $151.28M in aggregate; its largest disclosed positions were VSTM ($12.80M), TENX ($9.60M), NKTR ($8.42M).

How large is Stonepine Capital Management, LLC's portfolio?

Stonepine Capital Management, LLC reported $151.28M of long equity holdings across 83 positions as of 2026-Q2. Top-10 holdings account for 44.6% of reported value.

What is Stonepine Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/stonepine-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →